Innate Pharma obtains €6.8M in public funding for its COVID-19 research and development activitiesGlobeNewsWire • 08/11/20
INNATE PHARMA ANNOUNCES PUBLICATION OF EXPLORE COVID-19 TRANSLATIONAL STUDY FINDINGS IN NATUREGlobeNewsWire • 07/29/20
Innate Pharma announces the appointment of Joyson Karakunnel, MD, MSC, FACP as Chief Medical OfficerGlobeNewsWire • 07/16/20
U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TELLOMAK Trial in Advanced T-Cell LymphomasGlobeNewsWire • 06/24/20
U.S. Food and Drug Administration lifts partial clinical hold on lacutamab TELLOMAK trial in advanced T-cell lymphomasGlobeNewsWire • 06/24/20
Innate Pharma to Present New Efficacy Data For Monalizumab in Combination With Cetuximab in Head And Neck cancer at The ASCO20 Virtual Scientific ProgralGlobeNewsWire • 05/14/20
First patient dosed in avdoralimab Phase II clinical trial in COVID-19 patients with severe pneumoniaGlobeNewsWire • 04/28/20
First Patient Dosed in Avdoralimab Phase II Clinical Trial in COVID-19 Patients With Severe PneumoniaGlobeNewsWire • 04/28/20
Innate Pharma Files Its 2019 Universal Registration Document (Document d’enregistrement universel) and Its 2019 Annual Report on Form 20-FGlobeNewsWire • 04/24/20
Innate Pharma Files Its 2019 Universal Registration Document (Document d’Enregistrement Universel) and Its 2019 Annual Report on Form 20-FGlobeNewsWire • 04/24/20
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 19, 2020 Without the Physical Presence of Its ShareholdersGlobeNewsWire • 04/14/20
Innate Pharma SA (IPHYF) CEO Mondher Mahjoubi on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/15/20
First patient dosed in IPH5201 Phase I clinical trial in advanced solid tumorsGlobeNewsWire • 03/10/20
French Regulatory Agency Agrees lacutamab TELLOMAK Trial Can Resume Recruitment in Sezary Syndrome and mycosis fungoides.GlobeNewsWire • 01/13/20
French regulatory agency agrees lacutamab TELLOMAK trial can resume recruitment in Sézary syndrome and mycosis fungoidesGlobeNewsWire • 01/13/20
Innate Pharma Provides Update from Regulatory Agencies on Lacutamab TELLOMAK TrialGlobeNewsWire • 01/09/20